rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia

Clinical trial NCT07653581 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07653581
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lower-risk Myelodysplastic Syndromes

Start date: 2026-06-01
Primary completion: 2028-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.